Last updated on June 2018

Study of Pembrolizumab (MK-3475) in Participants With High Risk Non-muscle Invasive Bladder Cancer (MK-3475-057/KEYNOTE-057)


Brief description of study

In this study, participants with high risk non-muscle-invasive bladder cancer (NMIBC) unresponsive to Bacillus Calmette Guerin (BCG) therapy and who are considered ineligible for or have refused to undergo radical cystectomy, will receive pembrolizumab therapy. The primary study hypothesis is that treatment with pembrolizumab will result in a clinically meaningful response.

Clinical Study Identifier: NCT02625961

Contact Investigators or Research Sites near you

Start Over

Toll Free Number

Call for Information (Investigational Site 0022)
Duarte, CA United States
  Connect »

Toll Free Number

Call for Information (Investigational Site 0017)
Los Angeles, CA United States
  Connect »

Toll Free Number

Call for Information (Investigational Site 0021)
Orange, CA United States
  Connect »

Toll Free Number

Call for Information (Investigational Site 0032)
Santa Monica, CA United States
  Connect »

Toll Free Number

Call for Information (Investigational Site 0034)
Detroit, MI United States
  Connect »

Toll Free Number

Call for Information (Investigational Site 0023)
Minneapolis, MN United States
  Connect »

Toll Free Number

Call for Information (Investigational Site 0096)
Las Vegas, NV United States
  Connect »

Toll Free Number

Call for Information (Investigational Site 0002)
Hackensack, NJ United States
  Connect »

Toll Free Number

Call for Information (Investigational Site 0018)
New Brunswick, NJ United States
  Connect »

Toll Free Number

Call for Information (Investigational Site 0035)
Lake Success, NY United States
  Connect »

Toll Free Number

Call for Information (Investigational Site 0004)
New York, NY United States
  Connect »

Toll Free Number

Call for Information (Investigational Site 0025)
New York, NY United States
  Connect »

Toll Free Number

Call for Information (Investigational Site 0009)
Cleveland, OH United States
  Connect »

Toll Free Number

Call for Information (Investigational Site 0008)
Pittsburgh, PA United States
  Connect »

Toll Free Number

Call for Information (Investigational Site 0092)
Houston, TX United States
  Connect »

Toll Free Number

Call for Information (Investigational Site 0003)
Salt Lake City, UT United States
  Connect »

Australian Medical Information Centre

Merck Sharp & Dohme
North Ryde, Australia
  Connect »

MSD Online

MSD Brasil
Sao Paulo, Brazil
  Connect »

Katrin Moeschlin

MSD Finland Oy
Espoo, Finland
  Connect »

Valerie Bouchara

MSD France
Paris, France
  Connect »

Anna Aletra

Vianex, S.A. / MSD
Alimos, Greece
  Connect »

Paola Chiaretta Fattore

MSD Italia S.r.l.
Rome, Italy
  Connect »

Japan Call Center

MSD K.K.
Chiyoda-Ku, Tokyo, Japan
  Connect »

TaeYoun Jo

MSD Korea LTD
Seoul, Korea, Republic of
  Connect »

Arjan Ooms

Merck Sharp & Dohme BV
Haarlem, Netherlands
  Connect »

Tatiana Serebriakova

Merck Sharp & Dohme IDEA, Inc.
Moscow, Russian Federation
  Connect »

Katrin Moeschlin

MSD Sweden
Stockholm, Sweden
  Connect »

Betul Erdogan

Merck Sharp & Dohme Ilaclari Ltd. Sti
Istanbul, Turkey
  Connect »

Paul Duffy

Merck Sharp & Dohme Ltd.
Hoddesdon, United Kingdom
  Connect »

Toll Free Number

Call for Information (Investigational Site 0031)
Seattle, WA United States
  Connect »

Toll Free Number

Call for Information (Investigational Site 0026)
Boston, MA United States
  Connect »

Toll Free Number

Call for Information (Investigational Site 0073)
Voorhees, NJ United States
  Connect »

Toll Free Number

Call for Information (Investigational Site 0078)
Myrtle Beach, SC United States
  Connect »

Toll Free Number

Call for Information (Investigational Site 0079)
Virginia Beach, VA United States
  Connect »

Toll Free Number

Call for Information (Investigational Site 0074)
Bala-Cynwyd, PA United States
  Connect »

Toll Free Number

Call for Information (Investigational Site 0076)
Syracuse, NY United States
  Connect »

Toll Free Number

Call for Information (Investigational Site 0077)
Hanover, MD United States
  Connect »

Toll Free Number

Call for Information (Investigational Site 0072)
Cincinnati, OH United States
  Connect »